Keros Therapeutics Stock Options Expiring on 17th of January

KROS Stock  USD 15.64  0.46  2.86%   

Keros Therapeutics Corporate Management

Robin WagnerSenior ResourcesProfile
Simon MBBSChief OfficerProfile
Keith MBAChief OfficerProfile
Christopher MScChief OfficerProfile
John MBASenior ManagementProfile
Jennifer LacheyChief OfficerProfile
Jasbir SeehraCEO and PresidentProfile

Additional Tools for Keros Stock Analysis

When running Keros Therapeutics' price analysis, check to measure Keros Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Keros Therapeutics is operating at the current time. Most of Keros Therapeutics' value examination focuses on studying past and present price action to predict the probability of Keros Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Keros Therapeutics' price. Additionally, you may evaluate how the addition of Keros Therapeutics to your portfolios can decrease your overall portfolio volatility.